The subject of the contract is the successive delivery of the drug Dupilumab.
The subject of the contract is the successive delivery of the drug Dupilumab. Detailed parameters regarding the subject of the contract (description of the subject of the contract, estimated quantity) are specified in Annex 2 to the SWZ.